Extremely significant negative changes in Wave Life Sciences Ltd (NASDAQ: WVE) investment behavior have recently occurred: the stock’s recent price decline challenged its longer term uptrend, its shorter term price trend turned down, the stock fell on very heavy volume, and negative upside/downside volume developed.
In light of these highly negative signals we are reviewing our current Overall Rating of F. We would continue to view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
WVE’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to continue to be Value Creation neutral.
Wave Life Sciences has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Wave Life Sciences has a very low Appreciation Score of 1 but a neutral Power Rating of 51, leading to the Lowest Value Trend Rating.
Recent Price Action
Wave Life Sciences Ltd (NASDAQ: WVE) stock closed at $4.77 on 6/25/24 after a large decline of -8.4%. Moreover, trading volume in this decline was exceptionally high at 1439% of normal. The stock has performed in line with the market over the last nine months and has declined -23.4% during the last week.
Be the first to comment